SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections.
SaNOtize has raised $24.0M in total funding. The most recent round was Series B. The last funding was announced in August 2022.
SaNOtize's investors include OurCrowd, Agricultural Bank of China, Horizons Ventures, Angel Forum, Ginkgo Capital.
SaNOtize is headquartered in Vancouver, Canada.
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections.
SaNOtize is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SaNOtize — Funding & Investors." VCBacked, August 24, 2022, https://www.vcbacked.co/company/sanotize. Accessed August 15, 2026.
VCBacked. (2022). SaNOtize — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/sanotize
{{cite web |title=SaNOtize — Funding & Investors |url=https://www.vcbacked.co/company/sanotize |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated